RALEIGH, N.C., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq: BAXS ) announced today that it plans to release third quarter 2013 financial and operating results after market close on Wednesday, November 6, 2013. Ken Reali, President and Chief Executive Officer and Tim Shannon, Interim Chief Financial Officer, will host a conference call starting at 4:30 pm ET on the same day. To listen to the conference call on your telephone, please dial (877) 312-8823 for domestic callers and (253) 237-1182 for international callers approximately ten minutes prior to the start time. The call will be concurrently webcast. To access the live audio broadcast or archived recording, use the following link at http://ir.baxanosurgical.com/events.cfm .
About Baxano Surgical, Inc.
Baxano Surgical, Inc. is a medical device company focused on designing, developing, and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. Baxano Surgical currently markets the AxiaLIF ® family of products for single and two level lower lumbar fusion, the VEO ® lateral access and interbody fusion system, the iO-Flex ® system, a proprietary set of flexible instruments used by surgeons during spinal decompression procedures and the iO-Tome TM instrument, which rapidly and precisely removes bone, specifically the facet joints, which is commonly performed in spinal fusion procedures. Baxano Surgical was founded in May 2000 and is headquartered in Raleigh, North Carolina. For more information, visit www.baxanosurgical.com .
AxiaLIF, VEO, and iO-Flex are registered trademarks of Baxano Surgical.
Investors: Westwicke Partners Mark Klausner, 443-213-0501
